OncoTargets and Therapy
Volume 4, 2011 - Issue
Open access
56
Views
2
CrossRef citations to date
0
Altmetric
Review
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
Eva Muñoz-CouseloBreast Cancer Unit, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
, José Pérez-GarcíaBreast Cancer Unit, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
& Javier CortésBreast Cancer Unit, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, SpainCorrespondence[email protected]
Pages 185-192
|
Published online: 14 Nov 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.